AbbVie (ABBV) Other financing activities (2012 - 2026)

AbbVie (ABBV) has reported Other financing activities for 15 consecutive years, with $25.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other financing activities rose 733.33% year-over-year to $25.0 million in Q2 2026; TTM through Jun 2026 was $129.0 million, a 12.24% decrease from a year earlier, with the FY2025 full-year figure at $172.0 million, down 19.63% from the prior year.
• Other financing activities was $25.0 million for Q2 2026 at AbbVie, up from $2.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $128.0 million in Q1 2022 and troughed at $2.0 million in Q1 2026.
• A 5-year average of $47.5 million and a median of $48.0 million in 2023 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 733.33% in 2026, down 97.01% in 2026.
• Over 5 years, Other financing activities stood at $53.0 million in 2022, then slumped by 41.51% to $31.0 million in 2023, then tumbled by 67.74% to $10.0 million in 2024, then jumped by 380.0% to $48.0 million in 2025, then slumped by 47.92% to $25.0 million in 2026.
• The last three Other financing activities figures came in at $25.0 million (Q2 2026), $2.0 million (Q1 2026), and $48.0 million (Q4 2025), per Business Quant data.